The Sarcoma Journal Author Guidelines
THE SARCOMA JOURNAL (TSJ), the official journal of the Sarcoma Foundation of America (curesarcoma.org), is a quarterly, peer-reviewed journal committed to:
- Meeting the information needs of oncologists as they pertain to sarcoma.
- Publishing original research reports, review and state-of-the-art papers, case reports, research letters, commentaries, letters to the editor, columns/features, and news articles related to the diagnosis and treatment of sarcomas.
- Exploring electronic publication to enhance and supplement dissemination of original research and evidence-based information to become a vital clinical forum and resource for oncologists.
Manuscript Style and Format
Manuscripts should conform to the International Committee of Medical Journal Editors (ICMJE) Recommendations, which are available at www.icmje.org. For questions about style, consult the American Medical Association Manual of Style: A Guide for Authors and Editors. 10th ed. New York, NY.: Oxford University Press, 2007. Keep abbreviations and acronyms to a minimum and spell out on first reference, eg, Sarcoma Foundation of America (SFA). Regarding medications, generic drug names should generally be used. When proprietary brands are used in research, include the brand name in parentheses in the Methods section.
The title page should include from top to bottom: article title; name, degree, and institutional affiliation of each author; previous presentation of the work, if any; name and address/fax/e-mail of the corresponding author; and manuscript word count, excluding tables, figures, and abstract. Pages should be numbered consecutively in the upper right corner beginning with the title page.
Please see the links, above, for detailed information on specific article types and departments.
Acknowledgements: This section is optional and may be used to acknowledge substantial contributions to the research or preparation of the manuscript made by individuals other than the authors.
Conflict of Interest: Each article should have a statement acknowledging any potential conflict of interest. If there is none, please state "No conflict of interest."
Permissions: Contributors to TSJ may be asked to obtain permission from the author and publisher for the use of quotes, illustrations, tables, and other materials taken from previously published works not in the public domain. The original source should be mentioned in the table footnote.
Please note the following:
- Papers that exceed the stipulated word counts will be returned to the author(s) for editing before the paper is sent out for review.
- Papers in which the references do not follow style will also be returned to the author for revision.
